Cardiff Park Advisors’s NextCure NXTC Stock Holding History

Cardiff Park Advisors’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.9K	Hold	21,833	–	–	﹤0.01%	327
2026 Q1	$233K	Hold	21,833	–	–	0.02%	260
2025 Q4	$310K	Hold	21,833	–	–	0.03%	213
2025 Q3	$128K	Hold	21,833	–	–	0.01%	308
2025 Q2	$121K	Hold	21,833	–	–	0.01%	281
2025 Q1	$126K	Hold	21,833	–	–	0.01%	277
2024 Q4	$202K	Hold	21,833	–	–	0.02%	254
2024 Q3	$359K	Hold	21,833	–	–	0.03%	187
2024 Q2	$417K	Hold	21,833	–	–	0.04%	171
2024 Q1	$584K	Buy	+21,833	New	+$376K	0.06%	151
2023 Q3	–	Sell	-21,833	Closed	-$472K	–	321
2023 Q2	$472K	Buy	+21,833	New	+$430K	0.06%	152
2023 Q1	–	Sell	-21,833	Closed	-$369K	–	327
2022 Q4	$369K	Buy	+21,833	New	+$502K	0.05%	173

Other funds holding NXTC

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Verdad Advisers Boston, Massachusetts $104M AUM

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Cardiff Park Advisors's NXTC Position: Q2 2026 in Review

Cardiff Park Advisors held its NextCure (NXTC) position steady in Q2 2026 at 21,833 shares worth $34.9K. The position accounts for ﹤0.01% of the portfolio, ranked #327.

Cardiff Park Advisors first reported a position in NXTC in Q4 2022 and has held it in 12 quarters since. The position peaked at $584K in Q1 2024. 30 funds tracked by Wall St. Rank hold NXTC as of Q2 2026.

Cardiff Park Advisors held 21,833 shares of NextCure worth $34.9K as of Q2 2026.
Cardiff Park Advisors left its NextCure share count unchanged in Q2 2026.
NextCure made up ﹤0.01% of Cardiff Park Advisors's portfolio in Q2 2026, its #327 holding.
Cardiff Park Advisors first reported a position in NextCure in Q4 2022 and has held it in 12 quarters since.
Cardiff Park Advisors's NextCure position peaked at $584K in Q1 2024.
30 funds tracked by Wall St. Rank held NextCure as of Q2 2026.

Based on Cardiff Park Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.